Why is Retatrutide considered the next frontier in metabolic research? While GIP/GLP-1 agonists changed the game, Retatrutide adds a third target: the Glucagon receptor. This tri-agonist mechanism is being studied for its unprecedented benefits in weight management, where it not only helps regulate appetite but may also increase energy expenditure. It represents a paradigm shift for research into the complexities of obesity, type 2 diabetes, and overall metabolic health. * For research purposes only.!
